This inventor holds 1 USPTO granted patent. Top assignees: University of Michigan, Vanderbilt University. Active years: 2015.
Company Filing History:
1 out of 3,519 
1 out of 1,218 
Years Active: 2015
Title: The Innovations of Timothy J Senter
Introduction
Timothy J Senter is a notable inventor based in Nashville, TN (US). He has made significant contributions to the field of medical research, particularly in the development of compounds that target specific proteins involved in various diseases. His work has the potential to impact treatments for leukemia, solid cancers, diabetes, and other conditions.
Latest Patents
Timothy J Senter holds 1 patent for his invention titled "Menin-MLL inhibitors and methods of use thereof." This patent relates to compounds that inhibit the binding of menin and MLL or MLL fusion proteins. The invention provides compositions comprising piperidine-containing compounds and methods to inhibit the interaction of menin with MLL oncoproteins, which is crucial for the treatment of several diseases.
Career Highlights
Throughout his career, Timothy has worked with prestigious institutions such as the University of Michigan and Vanderbilt University. His research has focused on the development of innovative therapeutic strategies that leverage the inhibition of specific protein interactions.
Collaborations
Timothy has collaborated with notable researchers in his field, including Jolanta Grembecka and Tomasz Cierpicki. These collaborations have enhanced the depth and breadth of his research, contributing to advancements in medical science.
Conclusion
Timothy J Senter's work exemplifies the impact of innovative research on the treatment of serious diseases. His contributions to the field of medical research through his patent and collaborations highlight the importance of continued innovation in healthcare.